Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.
about
The role of EMMPRIN in T cell biology and immunological diseasesThe roles of CD147 and/or cyclophilin A in kidney diseasesThe Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I -Induced MyocarditisThe influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.Decrease in plasma cyclophilin A concentration at 1 month after myocardial infarction predicts better left ventricular performance and synchronicity at 6 months: a pilot study in patients with ST elevation myocardial infarctionFunction of CD147 in atherosclerosis and atherothrombosisNitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes.Knockdown of EMMPRIN improves adverse remodeling mediated by IL-18 in the post-infarcted heartTargeting extracellular cyclophilins ameliorates disease progression in experimental biliary atresia.EMMPRIN-Targeted Magnetic Nanoparticles for In Vivo Visualization and Regression of Acute Myocardial Infarction.Cyclophilin A: a key player for human diseaseBasigin rs8259 Polymorphism Confers Decreased Risk of Chronic Heart Failure in a Chinese Population.Methods employed for induction and analysis of experimental myocardial infarction in mice.Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites.Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases.CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.Extracellular cyclophilins in health and disease.Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.Inhibition of cyclophilin A suppresses H2O2-enhanced replication of HCMV through the p38 MAPK signaling pathway.Chemotactic Activity of Cyclophilin A in the Skin Mucus of Yellow Catfish (Pelteobagrus fulvidraco) and Its Active Site for Chemotaxis.Increased expression of EMMPRIN and VEGF in the rat brain after gamma irradiationCombined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury.Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy.Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation.The CD147/MMP-2 signaling pathway may regulate early stage cardiac remodelling in spontaneously hypertensive rats.The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice.CD147/basigin reflects renal dysfunction in patients with acute kidney injury.The recombinant bifunctional protein αCD133-GPVI promotes repair of the infarcted myocardium in miceRole of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma
P2860
Q26998829-0D9B5F97-81D6-41DE-8025-DDE6F766C1ECQ28083416-031EFC83-481B-4003-B75B-FEAC264C58B2Q30316634-25EBBC50-E9BA-4518-8F02-8810D711600DQ34257083-2C863E26-5BD6-4E5B-B4F8-0EF854C4AE05Q34780920-25EA9521-033D-4EA2-AF87-907D99638486Q35152073-26011E75-356F-4567-B89B-83A5BF60FA3BQ36138609-FE74A9F5-17B5-4807-ABB0-18A73211FD38Q36309504-213130F9-114E-40BB-AA76-F1E0665AA162Q36568302-3EB3F52F-1814-4E97-BDFC-0F98D9A9A9E7Q36644344-FD3DBF0B-ECA7-4C5C-B912-D713C1A6431CQ37577487-F0383F3D-9963-4634-93F9-B3227FE86D7BQ37678559-9998FA2E-0CCC-4741-8C31-708880F05015Q37922057-6EFAFF9E-9E40-46FE-B945-0174F1736C84Q38033589-F103D982-C076-4B35-B77A-1F87300C27ECQ38187226-B44A9A0A-A539-4FD8-A24D-F93321CB001FQ38253491-9B1A5DF4-F5A1-4099-8C4B-4E11E3885218Q38265843-EB874528-CF53-497E-B730-8A300C05AC4EQ38274888-2DB50637-2C9C-4CC7-8E08-682492500AD9Q38370240-CCF5FAE4-2120-4603-9E94-D3AE8C0A6338Q40535828-9099EA5E-6E82-4857-9E28-81D12436156AQ41190981-01CFD235-D978-406E-981C-116A094E54B2Q41554254-69A82056-DF79-4081-ADEB-9CEFD7E8835BQ41937646-5C01F1B5-7FB5-44CE-B10A-2EF8320FC59AQ43455968-DB8E3CD2-0D59-4B1A-BFE3-0BFFB4029FA3Q47428410-094CE1C1-7A9D-4DE6-A33B-DDE067C20292Q50117655-0CA333FB-A197-4D56-82E4-A58CE575AAF4Q50249518-435D60D6-1C81-4E30-955D-0B6C02A18116Q51620512-0F515D66-F5A9-4AEE-9AFE-6BB131C289CDQ51757699-1FB8C4F1-B1FE-41D5-8BC3-BAFF88E20C6DQ54489250-D9099FC5-EC80-4977-95EB-760268AC3C7EQ54592173-0AB87A93-4977-413E-9658-B89AE9E3AB72Q58702065-D9D5DC02-5ACA-45E7-B819-97487E04FA01
P2860
Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Disrupting the EMMPRIN (CD147) ...... dial ischemia and reperfusion.
@en
type
label
Disrupting the EMMPRIN (CD147) ...... dial ischemia and reperfusion.
@en
prefLabel
Disrupting the EMMPRIN (CD147) ...... dial ischemia and reperfusion.
@en
P2093
P2860
P50
P1476
Disrupting the EMMPRIN (CD147) ...... dial ischemia and reperfusion.
@en
P2093
Andreas E May
Carmen Ochmann
Florian Lang
H Robson MacDonald
Meinrad Gawaz
Melanie Rose
Oliver Borst
Peter Seizer
Romana A Nowak
Sebastian Zach
P2860
P304
P356
10.1161/ATVBAHA.111.225771
P407
P577
2011-03-24T00:00:00Z